PIPE-307

N/A

Report date: 2025/05/14 16:47:19
NME

Base Information

Drug NamePIPE-307
Drug Alias NameJNJ-5120PIPE-307
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 antagonists
TargetsMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesContineum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson Innovative MedicineContineum Therapeutics IncJanssen Pharmaceutica NV
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A